| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Rho Ventures VI LP last filed a Form 4 in March 2017, as 10% Owner at TVRD.
At the last filing, the largest reported position was 3,568,057 shares of TVRD. Net of sales, the TVRD filings show accumulation of 900,000 shares.
Rho Ventures VI LP has 2 Form 4 filings on record from March 2016 to March 2017, all as 10% Owner at Tvardi Therapeutics (TVRD), 2016–2017.
The 3 reported transactions were 3 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $11.0M and no sales.
The largest open-market purchase was 500,000 shares of TVRD at an average $18.19 on March 31, 2017, about $9.1M.
Shares as reported in the last Form 4 for each company; the most recent is from March 2017. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.